| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.27 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |